Riddhima Chakraborty | Page 2

December's job report showing steady job growth despite slowing wage inflation and analysts expecting inflation to have cooled further in the last month of 2022 are fueling optimism. So, we...

The stock market is expected to see a recovery in 2023. While value stocks are expected to outperform growth stocks this year as well, quality stocks, Mazda Motor (MZDAY), Good...

Retailers witnessed solid sales growth during the 2022 holiday season despite the macro headwinds. Given the industry's potential stability this year, quality big-box retail stocks Walmart (WMT) and Big Lots...

While a slowdown looks inevitable, the U.S. economy might narrowly avoid a recession this year. Moreover, experts believe the stock market can recover in 2023. Therefore, investors might consider buying...

The software industry witnessed solid growth during the pandemic and is expected to see continued growth amid rapid digitization. Given the favorable prospects of the industry, under-the-radar software stocks Synopsys...

Following the current market turmoil, a potential rebound is expected next year. Additionally, as value stocks are expected to beat growth counterparts, Stellantis (STLA), Celestica (CLS), LSI Industries (LYTS), and...

Despite rampant macro headwinds, market optimism is rising ahead of New Year's. Benchmark indices have been gaining over the past week. Also, inflation expectations are improving, raising hopes that the...

While a recession in 2023 looks inevitable amid lingering macro headwinds, experts believe it to be mild. Moreover, amid high hopes for a Santa Claus rally, quality stocks Stellantis (STLA),...

Biotech giant Moderna (MRNA) missed consensus revenue and EPS estimates in its 2022 third quarter. Moreover, it lost more than 17% in 2022. While analysts are bearish on MRNA's growth,...

Despite widespread macro headwinds, the U.S. economy and its tight labor market look resilient enough to sustain possible downturns in the upcoming term. Moreover, as the stock market is expected...

The Fed is expected to keep hiking rates well into 2023; consequently, the broader market might remain under pressure. However, value stocks have been gaining traction and are expected to...

Amid rising global medical needs, the pharmaceutical industry is expected to witness robust growth in the coming years. Moreover, healthcare is considered relatively resilient amid market downturns. So, given the...

The Fed announced a 50-bps rate hike this week, stepping down from its 75-bps raises for four consecutive times. With cooling inflation and reduced interest rate hikes, the economy might...

Inflation also cooled down in November, coming in lower than expected. With analysts expecting further decline in inflationary pressures, the Fed's pace of rate hikes could also see a slowdown....

The Fed is expected to slow down its rate hike aggression amid positive inflation data expectations. Moreover, the U.S. consumer sentiment remains strong despite rampant macro headwinds. Amid the broader...

Pharma company Rigel's (RIGL) REZLIDHIA recently achieved the U.S. Food and Drug Administration's approval for treating relapsed or refractory acute myeloid leukemia, helping the stock to soar. RIGL shares have...

AMC Entertainment (AMC) beat consensus estimates in its 2022 third quarter. However, the stock lost more than 63% in 2022. Also, its bottom line is in the red, and with...

Auto stock Nikola (NKLA) beat its revenue estimates for the 2022 third quarter. However, it missed the EPS estimates. Moreover, NKLA reduced its 2022 outlook amid an apparent demand downtrend....

Valero Energy (VLO) expanded its production for the fourth quarter anticipating increased demand. The stock is up nearly 70% in 2022. It is trading above its 50-day and 200-day moving...

Amid the Fed's monetary tightening policies, industrial production in the U.S. declined in October. However, the infrastructure bill, which has already approved numerous projects for industrial development, is expected to...

Salesforce (CRM) presented mixed financials for its 2022 third quarter. The company's management is confident of generating broad profit margins shortly. However, the company dismissed a section of its employees...

Fed Chair Jerome Powell has assured a slowdown in rate hikes might commence in December. Benchmark indices gained substantially over the Fed Chair's comments. Moreover, broader market gains from a...

Despite rampant market volatility ahead of the November jobs data, and possible recession fears, experts believe the U.S. economy is resilient enough to handle a potential growth slowdown. Given the...

Despite high booking prices, pent-up travel demand in the post-pandemic era is helping the travel industry to recover. Thanksgiving air travel propelled to the highest level in three years, and...

Following October's favorable inflation data, the Fed is expected to slow down its rate hike aggression. While there's a surge in investors' optimism, uncertainty remains. Therefore, investors looking to strengthen...

Favorable inflation data for October and rising anticipation of a slower pace of rate hikes ahead might bode well for the stock market. Fundstrat sees the market soaring to new...

Amid rampant macro headwinds, a recession seems imminent. However, following October's favorable inflation data, experts believe the chances of a 'soft landing' have increased. Moreover, bullish sentiment significantly improved over...

Despite the macro issues, many believe the U.S. economy might achieve a 'soft landing.' Moreover, amid surging optimism, the S&P 500 could pull off a year-end rally. However, as uncertainty...

Despite macro headwinds, U.S. retail sales increased month-over-month in October. With the economy showing resilience, the odds of the economy avoiding a deep recession are gradually rising. Although there's a...

While the October inflation report came in better than expected, it is far from the Fed's target. Amid rising recession odds, consumer sentiment is declining. Therefore, fundamentally weak stocks NVIDIA...